Merck (MRK) shares gain, Citi upgrades to buy as estimates ahead of consensus
Tweet Send to a Friend
Merck (NYSE: MRK) was lifted to Buy from Neutral, with its price target raised to $130 from $105 by Citi ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
